Catalyst Connection

At a Glance

Headquarters
Unknown, US

About

Sensars is pioneering neuromodulation for diabetic neuropathy with SENSY, the first system to restore natural sensations to the feet, preventing complications like ulcers, amputations, falls, and addressing chronic neuropathic pain. The company has over 25 peer-reviewed publications, successful clinical studies, and FDA Breakthrough Device Designation.

Capabilities & Markets

Directory supply chains

Products

End markets served

Classification

NAICS Codes

Compliance & Registrations

Certifications

FDA Breakthrough Device Designation

compliance_program

Filterable Certifications & Statuses

Quality Certifications
FDABREAKTHROUGHDEVICEDESIGNATION

Related Manufacturers